Clinical trial No longer in our active list Phase 4 Interventional Ages 60 and up

Investigating the effects of a sedation drug on cognition in elderly patients during colonoscopy

Official title: Effect on Early Cognition Under Sedation by Rimazole Toluenesulfonate in Old Patient Undergoing Colonoscopy

Run by RenJi Hospital · NCT05255211 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a sedation drug called Remimazolam affects thinking skills in older patients during a colonoscopy compared to another sedation option.

More Cognition trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages60 Years and up
SexAll
Enrollment90 (estimated)
SponsorRenJi Hospital
Academic / other
Locations1 site (Shanghai, Shanghai)
Trial IDNCT05255211 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are elderly patients classified as ASA I or II who require sedation for a colonoscopy.

Probably not a fit

Patients with preoperative cognitive impairments, depression, or significant health issues such as severe liver or kidney damage may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate how Remimazolam tosilate affects cognitive function in elderly patients undergoing colonoscopy. The study compares the cognitive outcomes of patients sedated with Remimazolam to those receiving Propofol and saline solution. By focusing on older adults, the trial seeks to address potential cognitive impairments associated with sedation during medical procedures. Participants will be carefully selected based on specific inclusion and exclusion criteria to ensure the validity of the results.

Why it matters

Potential benefit: If successful, this study could lead to improved sedation practices that minimize cognitive impairment in elderly patients during colonoscopy.

How similar studies have gone: While there is ongoing research into sedation effects on cognition, this specific approach using Remimazolam tosilate in elderly patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. ASA I\~II
2. patients will be treatmented by sedation under colonoscopy
3. sign informed consent

Exclusion Criteria:

(1) Preoperative depression and cognitive impairment

(2) Hearing or visual impairment;

(3) Drug abuse, alcoholism or long-term use of antidepressants;

(4) Cardiovascular and cerebrovascular accidents, neurological sequelae, or severe liver and kidney function damage occurred within 6 months

(5) BMI \< 18, BMI \> 30

(6) Confirmed or suspected allergy to the test drug

Where it's running

  • Yongming Chen
    Shanghai, Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.